Client Work Detail

On October 23, 2009, Aeterna Zentaris, a global biopharmaceutical company focused on endocrine therapy and oncology with its head office in Quebec City, completed an equity issuance by way of registered direct offering under a prospectus supplement in the United States of units comprised of common shares and common share purchase warrants for gross proceeds of US$5.5 million. Aeterna Zentaris intends to use the net proceeds of this transaction for general corporate purposes, including clinical development of its leading compounds. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., acted as sole placement agent.

Ogilvy Renault LLP acted as lead counsel to Aeterna Zentaris with a team led by Elliot Shapiro and including Steve Malas and Marie-Claude Mailloux (corporate and securities).